Editorial: probiotics in inflammatory bowel disease-wrong organisms, wrong disease, or flawed concepts? Authors' reply

D J Gracie^{1

2}, Y Derwa^{1

2}, P J Hamlin¹, A C Ford^{1

2}

Affiliations

¹ Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.
² Leeds Institute of Biomedical and Clinical Sciences, University of Leeds, Leeds, UK.

Editorial

D J Gracie et al. Aliment Pharmacol Ther. 2017 Sep.

. 2017 Sep;46(6):633-634.

doi: 10.1111/apt.14237.

D J Gracie^{1

2}, Y Derwa^{1

2}, P J Hamlin¹, A C Ford^{1

2}

¹ Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.
² Leeds Institute of Biomedical and Clinical Sciences, University of Leeds, Leeds, UK.

No abstract available

Comment on

Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease.
Derwa Y, Gracie DJ, Hamlin PJ, Ford AC. Derwa Y, et al. Aliment Pharmacol Ther. 2017 Aug;46(4):389-400. doi: 10.1111/apt.14203. Epub 2017 Jun 27. Aliment Pharmacol Ther. 2017. PMID: 28653751
Editorial: probiotics in inflammatory bowel disease-wrong organisms, wrong disease, or flawed concepts?
Shanahan F. Shanahan F. Aliment Pharmacol Ther. 2017 Sep;46(6):632-633. doi: 10.1111/apt.14230. Aliment Pharmacol Ther. 2017. PMID: 28805324 No abstract available.